Latest Ratios: P/E Ratio -4.5x · EV/EBITDA 11.3x · ROE -23.1%. (2001–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.3B | $4.6B | $7.6B | $17.0B | $11.2B | $18.8B | $15.4B | $15.3B | $12.2B | $14.8B | $11.5B |
| Enterprise Value | $17.0B | $16.3B | $19.6B | $29.3B | $24.8B | $22.5B | $18.4B | $19.0B | $15.3B | $17.9B | $13.8B |
| P/E Ratio → | -4.48 | — | — | 8.67 | 5.90 | 9.97 | 7.76 | 18.00 | 10.10 | 17.58 | 12.74 |
| P/S Ratio | 0.56 | 0.49 | 0.74 | 1.55 | 1.15 | 2.21 | 2.72 | 2.44 | 1.70 | 2.41 | 2.13 |
| P/B Ratio | 1.17 | 1.04 | 1.35 | 2.25 | 1.83 | 4.15 | 3.95 | 5.30 | 3.61 | 4.49 | 3.80 |
| P/FCF | 6.64 | 5.77 | 14.24 | 12.77 | 8.75 | 14.60 | 15.73 | 14.16 | 9.98 | 27.63 | 17.73 |
| P/OCF | 4.65 | 4.04 | 7.83 | 8.95 | 6.14 | 10.72 | 11.46 | 10.56 | 7.82 | 18.44 | 12.84 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.71 | 1.90 | 2.68 | 2.56 | 2.64 | 3.26 | 3.02 | 2.13 | 2.91 | 2.57 |
| EV / EBITDA | 11.26 | 10.80 | 155.18 | 12.21 | 13.35 | 9.68 | 18.05 | 15.97 | 9.11 | 14.82 | 11.70 |
| EV / EBIT | 22.17 | — | — | 15.39 | 13.57 | 9.62 | 7.80 | 17.22 | 9.34 | 14.93 | 11.97 |
| EV / FCF | — | 20.30 | 36.82 | 22.00 | 19.42 | 17.45 | 18.80 | 17.53 | 12.51 | 33.35 | 21.39 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.8% | 18.8% | 22.9% | 23.8% | 24.6% | 31.4% | 22.9% | 25.5% | 27.6% | 24.7% | 26.1% |
| Operating Margin | 8.0% | 8.0% | -6.8% | 15.4% | 14.2% | 22.8% | 11.7% | 13.2% | 18.6% | 14.7% | 16.6% |
| Net Profit Margin | -12.2% | -12.2% | -14.8% | 17.9% | 19.6% | 22.1% | 35.1% | 13.5% | 16.9% | 13.7% | 16.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -23.1% | -23.1% | -23.1% | 28.7% | 35.6% | 44.8% | 58.4% | 27.1% | 36.1% | 26.7% | 30.8% |
| ROA | -5.2% | -5.2% | -6.2% | 7.4% | 9.9% | 16.5% | 19.5% | 9.1% | 12.8% | 9.4% | 10.6% |
| ROIC | 3.4% | 3.4% | -2.8% | 6.4% | 7.4% | 19.3% | 7.4% | 9.6% | 15.6% | 11.5% | 13.1% |
| ROCE | 4.1% | 4.1% | -3.4% | 7.5% | 8.7% | 21.1% | 8.0% | 10.9% | 17.2% | 11.8% | 12.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.89 | 2.89 | 2.31 | 1.87 | 2.48 | 0.93 | 1.02 | 1.42 | 1.04 | 1.10 | 1.00 |
| Debt / EBITDA | 8.57 | 8.57 | 102.79 | 5.88 | 8.15 | 1.81 | 3.89 | 3.46 | 2.11 | 3.02 | 2.54 |
| Net Debt / Equity | — | 2.61 | 2.14 | 1.63 | 2.23 | 0.81 | 0.77 | 1.26 | 0.92 | 0.93 | 0.78 |
| Net Debt / EBITDA | 7.73 | 7.73 | 95.16 | 5.13 | 7.34 | 1.58 | 2.95 | 3.07 | 1.84 | 2.54 | 2.00 |
| Debt / FCF | — | 14.53 | 22.58 | 9.24 | 10.67 | 2.84 | 3.08 | 3.37 | 2.53 | 5.72 | 3.66 |
| Interest Coverage | -0.59 | -0.59 | -0.47 | 2.64 | 4.51 | 23.39 | 21.65 | 9.27 | 13.08 | 9.81 | 9.17 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | 1.55 | 1.34 | 1.53 | 1.63 | 1.52 | 1.91 | 1.58 | 1.62 | 1.79 | 2.30 |
| Quick Ratio | 0.94 | 0.94 | 0.74 | 0.95 | 0.93 | 0.91 | 1.41 | 0.98 | 1.03 | 1.21 | 1.63 |
| Cash Ratio | 0.34 | 0.34 | 0.25 | 0.44 | 0.37 | 0.22 | 0.75 | 0.29 | 0.26 | 0.39 | 0.62 |
| Asset Turnover | — | 0.44 | 0.45 | 0.41 | 0.37 | 0.71 | 0.52 | 0.66 | 0.77 | 0.64 | 0.64 |
| Inventory Turnover | 3.49 | 3.49 | 3.47 | 3.54 | 2.60 | 3.84 | 4.46 | 4.52 | 4.96 | 5.14 | 5.53 |
| Days Sales Outstanding | — | 56.10 | 57.31 | 59.52 | 77.51 | 71.27 | 80.16 | 68.46 | 67.24 | 73.12 | 69.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.2% | 0.3% | 4.1% | 1.8% | 2.7% | 1.6% | 1.9% | 2.0% | 2.3% | 1.6% | 1.8% |
| Payout Ratio | — | — | — | 15.6% | 15.7% | 16.1% | 14.8% | 35.2% | 23.2% | 28.6% | 22.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 11.5% | 17.0% | 10.0% | 12.9% | 5.6% | 9.9% | 5.7% | 7.8% |
| FCF Yield | 15.1% | 17.3% | 7.0% | 7.8% | 11.4% | 6.8% | 6.4% | 7.1% | 10.0% | 3.6% | 5.6% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 5.3% | 4.2% | 6.5% | 6.6% | 3.4% | 4.4% |
| Total Shareholder Yield | 0.2% | 0.3% | 4.1% | 1.8% | 2.8% | 6.9% | 6.1% | 8.4% | 8.9% | 5.0% | 6.1% |
| Shares Outstanding | — | $110M | $109M | $109M | $109M | $112M | $118M | $125M | $135M | $138M | $146M |
High leverage and cyclicality
Based on reported figures, the forward P/E of 8.02 suggests that the market is pricing in significant earnings recovery, yet the negative TTM P/E of -4.64 highlights the severe impact of recent non-recurring charges on the company's headline valuation metrics compared to historical norms.
The current valuation appears to be heavily influenced by the market's skepticism regarding the timing of a cyclical turnaround in the chemical sector. Investors should monitor whether the forward multiple is justified by operational improvements or if it reflects an overly optimistic outlook on margin expansion in the Engineered Materials segment.
According to recent quarterly data, ROIC has struggled to maintain positive territory, falling to 1.0% in 2026Q1, which indicates that the company is currently failing to generate returns on invested capital that exceed its likely cost of capital following the M&M acquisition.
The persistent decay in ROIC suggests that the capital deployed for inorganic growth has not yet reached the expected efficiency levels. This trend warrants further investigation into whether the integration of recent assets is structurally impairing the company's ability to compound value for shareholders.
As reported in financial statements, the cash conversion cycle reached 104 days in 2026Q1, driven by elevated inventory days of 108, which suggests that the company is facing significant challenges in optimizing its working capital efficiency amidst a period of global industrial destocking.
The high inventory levels relative to historical averages may indicate a mismatch between production volumes and end-market demand. This inefficiency ties up critical liquidity and increases the risk of future inventory write-downs if pricing power in the Acetyl Chain continues to weaken.
Based on the provided data, the debt-to-EBITDA ratio of 31.86 in 2026Q1 represents a precarious leverage profile that significantly exceeds peer averages, suggesting that the company's ability to service its debt is increasingly sensitive to even minor fluctuations in operating cash flow.
The interest coverage ratio, which has dipped near parity in recent quarters, indicates that the company has very little margin for error in its debt service obligations. Investors should monitor the company's refinancing schedule closely, as the current leverage levels appear to be a primary constraint on strategic capital allocation.
The P/E ratio is frequently misapplied to this business model because it fails to account for the massive, non-cash acquisition-related impairments that distort net income, making EV/EBITDA a far more reliable metric for assessing the company's true operational earning power and leverage.
Relying on P/E in a period of heavy restructuring and integration leads to a distorted view of the company's valuation. Analysts should instead focus on normalized EBITDA and free cash flow to better understand the underlying cash-generating capacity of the integrated Acetyl Chain and Engineered Materials segments.
Includes 30+ ratios · 25 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CE stock.
Celanese Corporation's current P/E ratio is -4.5x. The historical average is 12.9x.
Celanese Corporation's current EV/EBITDA is 11.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.5x.
Celanese Corporation's return on equity (ROE) is -23.1%. The historical average is 32.4%.
Based on historical data, Celanese Corporation is trading at a P/E of -4.5x. Compare with industry peers and growth rates for a complete picture.
Celanese Corporation's current dividend yield is 0.25%.
Celanese Corporation has 18.8% gross margin and 8.0% operating margin.
Celanese Corporation's Debt/EBITDA ratio is 8.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.